首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1674099

口蹄疫疫苗市場：依疫苗類型、動物類型和地區分類

Foot and Mouth Disease Vaccine Market, By Vaccine Type, By Animal Type, By Geography

出版日期: 2025年02月14日 | 出版商:

Coherent Market Insights | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025年全球口蹄疫疫苗市場規模估計為31.5億美元，預計2032年將達到56.6億美元，2025年至2032年的複合年成長率為8.7%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	31.5億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	8.70％	2032 年金額預測	56.6億美元

數字。 2025 年口蹄疫疫苗市場佔有率（按地區分類）

口蹄疫（FMD）是一種高度傳染性的病毒性疾病，影響有蹄動物，包括牛、豬、羊、山羊、鹿和其他牲畜。該疾病造成了嚴重損害，包括直接造成牛奶產量和受感染動物的生長損失，以及因控制、治療和貿易限制而造成的間接經濟損失。口蹄疫在亞洲、非洲和南美洲部分地區流行，這些地區正在進行緊急疫苗接種工作以控制疫情。國際貿易和牲畜流動的增加使口蹄疫控制更具挑戰性，需要改善疫苗接種策略和干涉措施。

市場動態

全球口蹄疫疫苗市場的成長受到多種因素的推動，例如牲畜口蹄疫流行率的上升、氣候和農業實踐變化導致的全球疫情擴大以及動物和動物產品的國際貿易。然而，疫苗生產、儲存和設備重複使用相關的高成本可能會阻礙市場成長。此外，各國疫苗核准監管指南缺乏標準化也阻礙了市場的成長。分子生物學技術的機會發展，使得開發具有更高免疫抗原性和交叉保護能力的新一代疫苗成為可能，這可能為市場成長提供機會。人們對先前無口蹄疫的國家控制口蹄疫的興趣日益濃厚，這可能會開闢新的應用領域。

研究的主要特點

本報告對全球口蹄疫疫苗市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球口蹄疫疫苗市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球口蹄疫疫苗市場報告針對該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過全球口蹄疫疫苗市場分析中使用的各種策略矩陣來做出決策。

公司簡介
- Bayer AG
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.（MSD Animal Health）
- Indian Immunologicals Ltd.
- Limber Laboratories Pvt. Ltd.
- Brilliant Bio Pharma Private Limited
- Inova BIoTechnologia Saude Animal Ltda.
- Biovet Vaxxinova
- Veterquimica SA
- MEVAC
- Agrovet
- Biogenesis Bago
- FGBI-Federal Centre for Animal Health
- Vecol SA
- Laboratorios Agrovet SA
- Centro Diagnostico Veterinario
- Razi Vaccine & Serum Research Institute
- VETAL Animal Health Veterinary Pharmaceuticals

第 9 章分析師建議

興衰
一致的機會地圖

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1945

Global Foot And Mouth Disease Vaccine Market is estimated to be valued at USD 3.15 Bn in 2025 and is expected to reach USD 5.66 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.15 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.70%	2032 Value Projection:	USD 5.66 Bn

Figure. Foot And Mouth Disease Vaccine Market Share (%), By Region 2025

Foot and Mouth Disease Vaccine Market - IMG1

Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals including cattle, pigs, sheep, goats, deer and other livestock. The disease can cause severe damage both direct loss in milk yield and growth in infected animals and indirect economic losses from control, treatment and trade restrictions. FMD is a endemic in parts of Asia, Africa, and South America where emergency vaccination is practiced to control outbreaks. With growing international trade and movement of livestock, controlling FMD has become more challenging, thus, requiring improved vaccination strategies and interventions.

Market Dynamics:

Global foot and mouth disease vaccine market growth is driven by factors such as increasing prevalence of FMD amongst livestock, growing outbreaks worldwide due to changes in climate and farming practices as well as international trade in animals and animal products. However, high costs associated with vaccine production and storage and reuse of equipment can hamper the market growth. Furthermore, lack of standardized regulatory guidelines for vaccine approval in different countries also hampers the market growth. Advancements in molecular biological techniques that enables development of new generation vaccines with improved immunogenicity and cross-protection can offer market growth opportunity. Growing focus on controlling FMD in previously FMD-free countries can open new application areas.

Key Features of the Study:

This report provides in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global foot and mouth disease vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Biogenesis Bago, Indian Immunologicals Ltd., Boehringer Ingelheim, Vetal Animal Health
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation

By Vaccine Type:
- Conventional Vaccine
- Aluminum Hydroxide based vaccine
- Oil based vaccines
- Emergency Vaccines
By Animal Type
- Cattle
- Sheep and Goat
- Swine
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Bayer AG
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc. (MSD Animal Health)
- Indian Immunologicals Ltd.
- Limber Laboratories Pvt. Ltd.
- Brilliant Bio Pharma Private Limited
- Inova Biotechnologia Saude Animal Ltda.
- Biovet Vaxxinova
- Veterquimica S.A.
- MEVAC
- Agrovet
- Biogenesis Bago
- FGBI - Federal Centre for Animal Health
- Vecol S.A.
- Laboratorios Agrovet S.A.
- Centro Diagnostico Veterinario
- Razi Vaccine & Serum Research Institute
- VETAL Animal Health Veterinary Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Foot and Mouth Disease Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Foot and Mouth Disease Vaccine Market, By Vaccine Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Conventional Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Aluminum Hydroxide based vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oil based Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Emergency Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Foot and Mouth Disease Vaccine Market, By Animal Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cattle
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sheep and Goat
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Swine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Foot and Mouth Disease Vaccine Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc. (MSD Animal Health)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Indian Immunologicals Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Limber Laboratories Pvt. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Brilliant Bio Pharma Private Limited
- Inova Biotechnologia Saude Animal Ltda.
- Biovet Vaxxinova
- Veterquimica S.A.
- MEVAC
- Agrovet
- Biogenesis Bago
- FGBI - Federal Centre for Animal Health
- Vecol S.A.
- Laboratorios Agrovet S.A.
- Centro Diagnostico Veterinario
- Razi Vaccine & Serum Research Institute
- VETAL Animal Health Veterinary Pharmaceuticals